Timothy Scannell's Trading History
| MASIMasimo | Jun 12, 2026 | ― | Uninformative Sell | 469.44K | $0.00 | |
| NVCRNovoCure | Jun 05, 2026 | Director | Uninformative Buy | ― | $340.56K | |
| PODDInsulet | May 21, 2026 | Director | Uninformative Buy | ― | $4.94M | |
| EXASExact Sciences | Nov 01, 2023 | ― | Uninformative Buy | ― | $597.36K | |
| SYKStryker | Aug 03, 2021 | President & COO | Uninformative Buy | 484.17K | $65.73M | |
| MKULQMolekule Group | ― | ― | ― | ― |
You May Also Like
Timothy Scannell insider profile FAQ
What is the percentage of profitable transactions made by Timothy Scannell?
The percentage of profitable transactions made by Timothy Scannell is 35%.
What is the average return per transaction made by Timothy Scannell?
The average return per transaction made by Timothy Scannell is -16.50%.
What stocks does Timothy Scannell hold?
Timothy Scannell holds: NVCR, EXAS, MASI, SYK, MKULQ, PODD stocks.
What was Timothy Scannell’s latest transaction?
Timothy Scannell’s latest transaction was an Uninformative Sell of $469.44K.
What was Timothy Scannell's most profitable transaction?
Timothy Scannell’s most profitable transaction was an Informative Sell of NVCR stock on June 6, 2024. The return on the trade was 23.20%.
What is Timothy Scannell's role in NovoCure?
Timothy Scannell's role in NovoCure is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.